Market Overview:
Western blotting is a laboratory technique used to detect specific proteins in a sample of tissue homogenate or extract. It uses gel electrophoresis to separate native or denatured proteins by the length of the polypeptide chain. The separated proteins are then transferred to a membrane, where they are stained with antibodies specific to the target protein or detected using chemiluminescent, radioisotopic or fluorescent markers.
The global Western Blotting Market is estimated to be valued at US$ 759.5 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the western blotting market is the development and commercialization of advanced product offerings. Vendors are focusing on introducing innovative and user-friendly solutions to gain competitive advantage. For instance, in 2021, Azure Biosystems launched MagniPhi Western automation system for western blotting. The system automates the western blot workflow from sample preparation to result analysis. It helps in reducing hands-on time and improves reproducibility by standardizing the protocol. Similarly, in 2019, LI-COR Biosciences introduced Odyssey CLx Western Blot Imaging System with Artificial Intelligence (AI) powered software. The system uses deep learning algorithms to automatically detect and quantify bands, thus providing faster and more accurate results compared to traditional blot imaging. Such advanced product offerings are elevating the western blotting experience and contributing to the market growth.
Segment Analysis
The western blotting market is segmented based on product, application, end-user, and region. By product, the market is classified into instruments, consumables, and others. The consumables segment dominated the market in 2023 due to the recurring use of reagents and kits in western blotting procedures.
Key Takeaways
Market size
The global western blotting market is expected to witness high growth, exhibiting CAGR of 6.8% over the forecast period, due to increasing biomedical research activities and growing use of western blotting in disease diagnostics.
Regional analysis
North America dominated the global western blotting market in 2023 owing to strong presence of key players, availability of advanced technologies, and increasing R&D expenditure on drug discovery and life science research in the region.
Key players
Key players operating in the western blotting market are Thermo Fisher Scientific, Inc., GE HealthCare, F. Hoffmann-La Roche Ltd, Lumigen, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., LI-COR, Inc., Bio-Techne, SBH Sciences, Advansta Inc., Azure Biosystems Inc., HiMedia Laboratories., Elabscience Biotechnology Inc., GenScript, Cell Signaling Technology, Inc., ICL, Inc., Takara Bio Inc., Leinco Technologies.
No comments:
Post a Comment